PATENT CLAIM ANALYSIS

Application Number: 16025386
Application Type: Utility
Filing Date: 2018-07
Publication Date: 2018-10
Patent Classification: ["514", "638000"]

Abstract:
A method for treating benign prostatic hyperplasia (BPH), prostatitis, and/or prostate cancer, including the step of administering an isothiocyanate functional surfactant to a patient affected by benign prostatic hyperplasia, prostatitis, and/or prostate cancer. In a preferred embodiment, the protonated form of the isothiocyanate functional surfactant is represented by the following chemical structure:

Claim (Index 13):
The method for treating benign prostatic hyperplasia, prostatitis, and/or prostate cancer according to  claim 12 , wherein the amount of isothiocyanate functional surfactant topically administered to the patient ranges from approximately 0.5 nmol/cm2 to approximately 10 \u03bcmol/cm2.

Metadata:
- Claim Count in Document: 41.0
- Percentile: 95.0
- Lexical Diversity: 1.5122
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15423869', '14519510', '16025579', '16025640', '15792097']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7982469510622074
- 35 USC 102 Novelty (BERT): 0.5616858867467888
- Combined Prediction Score: 0.7745908446306656
- Mean Citation Score: 405.885614
- Max Citation Score: 422.8746
- Similarity Product: 365.015024301517

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test